Drugs / BST104
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04008901 Comparator | Feb 2017 → Jul 2018 | dyspepsia, irritable bowel syndrome | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BST104 | “The randomly assigned target was given a Lonicera Flos extract (BST104) 175 mg/day for eight weeks.” NCT04008901 ↗ |
| Known as | Lonicera Flos Extract | “Drug: BST-104 (Lonicera Flos Extract)” NCT04008901 ↗ |